Medical researchers in the UK and Australia have identified a new marker they say could support the search for novel preventative and therapeutic treatments for dementia. 

Cochlear (ASX:COH) has announced that its chief financial officer Brent Cubis has tendered his resignation and will depart the company at the end of the calendar year to pursue other opportunities.

In order to better understand how innovation perspectives and actions are changing across Australian business leaders, as we adjust to a new post-COVID operating environment, KPMG’s Digital Delta Innovation Strategy team invites you to complete a short survey.

Telix Pharmaceuticals (ASX:TLX) says it has entered into a strategic collaboration agreement with US-based RefleXion Medical.

Australian company Cellmid (ASX:CDY) has signed an exclusive distribution agreement with Hong Kong-based company Immunodiagnostics for laboratory-based, quantitative Enzyme-Linked Immunosorbent Assays (ELISA’s) and a point of care serology test for SARS-CoV-2 for Australia and New Zealand.

Australia has topped all three categories in a new report commissioned by Roche looking at country approaches to cancer in the Asia Pacific region.

A new report from ANDHealth has found Australia’s emerging digital health industry has the potential to take advantage of growing global demand but that the COVID-19 pandemic has 'disrupted' the opportunity.

As the Senate Inquiry considering the Research and Development Tax Incentive (RDTI) Bill takes its final evidence and deliberates ahead of it August reporting date, AusBiotech stands steadfastly united with industry in its call for the Bill to be scrapped.